Join me as we finish our discussion on anueplody screening. In this episode we discuss the risks of amniocentisis and chorionic villus sampling, cell-free DNA, and different screening strategies. Comparing Different Strategies The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort   Amnio/CVS A report of the safety and accuracy of midtrimester amniocentesis at the Medical College of Georgia: Eight and one half years' experience PRENATAL DIAGNOSIS IN MULTIPLE GESTATION: 20 YEARS’ EXPERIENCE WITH AMNIOCENTESIS Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping Chorionic Villus Sampling Fetal Complications of Amniocentesis Intrauterine diagnosis and management of genetic defects Role of Amniocentesis in the Intrauterine Detection of Genetic Disorders Needle puncture of fetus: A complication of second- trimester amniocentesis Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study Procedure-Related Complications of Amniocentesis and Chorionic Villous Sampling Analysis of 2136 genetic amniocenteses: Experience of a single physician Midtrimester amniocentesis: An analysis of 923 cases with neonatal follow-up Cell-Free DNA Presence of fetal DNA in maternal plasma and serum Increased Fetal DNA Concentrations in the Plasma of Pregnant Women Carrying Fetuses with Trisomy 21 Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses Noninvasive Prenatal Detection of Aneuploidy Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection